Q4 2024 Management View CEO Joseph Dowling highlighted the company’s focus on scaling its business, achieving cost efficiencies, and transitioning to a global health and wellness company. He noted a ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...

CV Sciences, Inc. has launched a new plant-based food line under the brand name Lunar Fox Food Co. The product range offers a ...

Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Thursday it's ...

Greetings and welcome to the CV Sciences’ Fourth Quarter and Year-End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and ...

Recognized gross margin of 45.6% for fiscal year 2024, a significant improvement from 44.3% for 2023; Gross margin of 43.2% for the fourth quarter 2024 compared to 45.8% for the fourth quarter 2023 ...

CV Sciences Inc. (CVSI) reported its financial results for the fourth quarter and full year of 2024, showing steady revenue figures and strategic operational shifts. The company’s revenue for the year ...

Operator: Greetings. Welcome to the CV Sciences Fourth Quarter and Year End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and ...